Dr Angela Reiersen (pronounced Ray-er-sen) - originator of idea of Fluvoxamine for covid19 and principal investigator on early Fluvoxamine trials, as well as recent positive TOGETHER trial.

She hosts 4 clubhouse dot com informative sessions - you will need to download an app (Android/iPhone) - for signup (free),give phone number to receive confirmation SMS to signup. So signup is similar to WhatsApp, but you don't have to allow access to contacts.

Sessions are live or can listen later to replay as well (I think).

 

 

---

https://twitter.com/AngelaReiersen/status/1472029038713741314?t=B6_7U_D7fHrW1lPBO_TRdQ&s=19

Angela Reiersen, MD, MPE

Join me on the clubhouse app for one or more of these fluvoxamine related rooms this weekend (Saturday & Sunday). https://t.co/YhUcU53CyN

 

Mechanisms:

https://www.clubhouse.com/event/m3zdO0gZ

Evidence - RCTs etc.:

https://www.clubhouse.com/event/M1J7XRRm

Role of Psychiatrists for covid19:

https://www.clubhouse.com/event/xo2rD9B5

Practical info - with Dr Angela Reiersen, Dr Eric Osgood, Dr Farid Jalali etc.

https://www.clubhouse.com/event/xjj7V3ox

 

 

---

References:

https://www.frontiersin.org/articles/10.3389/fphar.2021.652688/full

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden and Vidula V. Sukhatme

20 April 2021

 

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786136

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants

Tomiko Oskotsky, MD; Ivana Marić, PhD; Alice Tang, BS; Boris Oskotsky, PhD; Ronald J. Wong, PhD; Nima Aghaeepour, PhD; Marina Sirota, PhD; David K. Stevenson, MD

November 15, 2021

 

https://www.psychiatrist.com/jcp/covid-19/repurposing-psychiatry-during-covid/

COMMENTARY

"What Were You Before the War?" Repurposing Psychiatry During the COVID-19 Pandemic

Ginger E. Nicol, MD; Jordan F. Karp, MD; Angela M. Reiersen, MD, MPE; Charles F. Zorumski, MD; and Eric J. Lenze, MD

 

Dr Angela Reiersen - Fluvoxamine FAQ:

https://healthymind.wustl.edu/

Fluvoxamine for Early Treatment of COVID-19: What You Should Know

 

https://pubmed.ncbi.nlm.nih.gov/34385600/

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Nicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Katrin Anne Becker, Angela M Reiersen, Eric J Lenze, David Seftel, Cédric Lemogne, Frédéric Limosin

August 12, 2021

 

https://link.springer.com/article/10.1007/s40265-021-01636-5

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence

Shelley N. Facente, Angela M. Reiersen, Eric J. Lenze, David R. Boulware & Jeffrey D. Klausner

December 1, 2021

 

https://www.science.org/doi/10.1126/scitranslmed.aau5266

Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis

DORIAN A. ROSEN, SCOTT M. SEKIANTHONY FERNÁNDEZ-CASTAÑEDA, REBECCA M. BEITER, JACOB D. ECCLES, JUDITH A. WOODFOLK AND ALBAN GAULTIER

6 February 2019

 

Dr Angela Reiersen article on how she arrived at Fluvoxamine as a candidate for covid19 early treatment:

https://online.flippingbook.com/view/329200553/9/

Following Your Instincts

Dr Angela Reiersen

Cerebrum Spring 2021

 

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1686-9620

Review

Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease Prevention

Madeline J. Nykamp, Charles F. Zorumski, Angela M. Reiersen, Ginger E. Nicol, John Cirrito, Eric J. Lenze

 

https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.2317

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study

Nicolas Hoertel, Marina Sánchez-Rico,Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Eric J. Lenze, Angela M. Reiersen, Miriam Abellán, Pedro de la Muela, Raphaël Vernet, Carlos Blanco, Céline Cougoule, Nathanaël Beeker, Antoine Neuraz, Philip Gorwood, Jesús M. Alvarado, Pierre Meneton, Frédéric Limosin

29 May 2021

 

https://pubmed.ncbi.nlm.nih.gov/34326236/

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A Tummino, Veronica V Rezelj, Benoit Fischer, Audrey Fischer, Matthew J O'Meara, Blandine Monel, Thomas Vallet, Kris M White, Ziyang Zhang, Assaf Alon, Heiko Schadt, Henry R O'Donnell, Jiankun Lyu, Romel Rosales, Briana L McGovern, Raveen Rathnasinghe, Sonia Jangra, Michael Schotsaert, Jean-René Galarneau, Nevan J Krogan, Laszlo Urban, Kevan M Shokat, Andrew C Kruse, Adolfo García-Sastre, Olivier Schwartz, Francesca Moretti, Marco Vignuzzi, Francois Pognan, Brian K Shoichet

July 30, 2021

 

https://pubmed.ncbi.nlm.nih.gov/34608263/

The acid sphingomyelinase/ceramide system in COVID-19

Johannes Kornhuber, Nicolas Hoertel, Erich Gulbins 

Oct 4, 2021